| Lisa Liang Alicea, MD | |
|
123 Medical Park Ln Ste A, Huntsville, TX 77340-4981 | |
| (936) 291-2116 | |
| (844) 655-5471 |
| Full Name | Lisa Liang Alicea |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 123 Medical Park Ln Ste A, Huntsville, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689297202 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | BP10070765 (Texas) | Primary |
| Entity Name | Huntsville Family Medicine, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871535559 PECOS PAC ID: 2769446590 Enrollment ID: O20041112000172 |
News Archive
A woman is more likely to miscarry if she and her partner drink more than two caffeinated beverages a day during the weeks leading up to conception, according to a new study from researchers at the National Institutes of Health and Ohio State University, Columbus.
World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has completed its previously announced private placement of common stock and warrants to purchase common stock. Gross proceeds from the offering were approximately $7.3 million. Proceeds from the private placement are expected to be used for general corporate and working capital purposes.
A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don't have it.
QLT Inc. today announced that it has initiated enrollment in a Phase Ib trial of QLT091001 in pediatric patients with Leber Congenital Amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
A recent discovery shows that antibodies produced by shark immune systems could be used to detect a range of human pathogens some of which have the potential to be used as biological warfare agents.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa Liang Alicea, MD 123 Medical Park Ln Ste A, Huntsville, TX 77340-4981 Ph: (936) 291-2116 | Lisa Liang Alicea, MD 123 Medical Park Ln Ste A, Huntsville, TX 77340-4981 Ph: (936) 291-2116 |
News Archive
A woman is more likely to miscarry if she and her partner drink more than two caffeinated beverages a day during the weeks leading up to conception, according to a new study from researchers at the National Institutes of Health and Ohio State University, Columbus.
World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has completed its previously announced private placement of common stock and warrants to purchase common stock. Gross proceeds from the offering were approximately $7.3 million. Proceeds from the private placement are expected to be used for general corporate and working capital purposes.
A team of researchers are developing the use of an artificial intelligence (AI) algorithm with the aim of diagnosing deep vein thrombosis (DVT) more quickly and as effectively as traditional radiologist-interpreted diagnostic scans, potentially cutting down long patient waiting lists and avoiding patients unnecessarily receiving drugs to treat DVT when they don't have it.
QLT Inc. today announced that it has initiated enrollment in a Phase Ib trial of QLT091001 in pediatric patients with Leber Congenital Amaurosis (LCA), an inherited progressive retinal degenerative disease that leads to retinal dysfunction and visual impairment beginning at birth. QLT091001 is an orally administered synthetic retinoid replacement for 11-cis-retinal, which is a key biochemical component of the visual retinoid cycle.
A recent discovery shows that antibodies produced by shark immune systems could be used to detect a range of human pathogens some of which have the potential to be used as biological warfare agents.
› Verified 1 days ago
Micah Ryan Bosley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Pkwy Ste 1000, Huntsville, TX 77340 Phone: 936-295-8000 | |
Dr. Thomas C Cole Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1203 Avenue J, Huntsville, TX 77340 Phone: 936-295-3728 | |
Lawrence E Ede, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 227 State Highway 75 N Ste 130, Huntsville, TX 77320 Phone: 936-539-4004 Fax: 936-291-0746 | |
Owen Joseph Murray, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 Medical Center Pkwy, Suite 2, Huntsville, TX 77340 Phone: 936-293-3655 Fax: 936-436-1142 | |
Lane Aiena, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Park Ln Ste A, Huntsville, TX 77340 Phone: 936-291-2116 Fax: 936-435-7824 | |
Lowell Gay Rollins Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Medical Center Pkwy Ste 1000, Huntsville, TX 77340 Phone: 936-295-8000 Fax: 936-439-1169 | |
Brian Mcnelis, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Memorial Dr, Huntsville, TX 77340 Phone: 877-832-2652 Fax: 361-371-8376 |